Skip to content
value.today

EndoShape, Inc.

🇺🇸 Boulder, Colorado, USABiotechnologyFounded 2006
Total raised
$27 M
5 rounds on record
Latest round
$4 M
Jan 2017
First round on record
Apr 2011
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of EndoShape, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2017$4 MNo. 5$2 to $10 million

EndoShape, Inc.: Raise no. 5, Jan 2017

Investors in this round

2 investors had bought by the notice of Feb 8, 2017: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $6 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert Kline · Executive Officer
  • Bryan Grulke · Director
  • James McGuckin · Director
  • Lee Geist · Director
  • Lindsay Carter · Director
  • Mark Lupa · Director
  • Richard Ferrari · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Kline, Ceo. Source: SEC Form D, newest notice filed Feb 8, 2017. Read the notice at the SEC.

equitySEC
Feb 2016$10 MNo. 4$10 to $50 million

EndoShape, Inc.: Raise no. 4, Feb 2016

Investors in this round

16 investors had bought by the notice of Mar 21, 2017: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert Kline · Executive Officer, Director
  • Bryan Grulke · Director
  • James McGuckin · Director
  • Lee Geist · Director
  • Lindsay Carter · Director
  • Mark Lupa · Director
  • Richard Ferrari · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Kline, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Mar 21, 2017. Read the notice at the SEC.

equitySEC
Jul 2015$3 MNo. 3$2 to $10 million

EndoShape, Inc.: Raise no. 3, Jul 2015

Investors in this round

16 investors had bought by the notice of Jan 27, 2016: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered; $0 M still to sell
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robin Shandas · Executive Officer, Director
  • William Aldrich · Executive Officer, Director
  • Lee Geist · Director
  • Mark Lupa · Director
  • Richard Ferrari · Director
  • Shawn Fojtik · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William Aldrich, President and CEO. Source: SEC Form D and 2 amendments, newest notice filed Jan 27, 2016. Read the notice at the SEC.

debt, optionsSEC
Jun 2014$6 MNo. 2$2 to $10 million

EndoShape, Inc.: Raise no. 2, Jun 2014

Investors in this round

17 investors had bought by the notice of Jun 19, 2014: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $7 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robin Shandas · Executive Officer, Director
  • William Aldrich · Executive Officer, Director
  • Lee Geist · Director
  • Mark Lupa · Director
  • Richard Ferrari · Director
  • Shawn Fojtik · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William Aldrich, President and CEO. Source: SEC Form D, newest notice filed Jun 19, 2014. Read the notice at the SEC.

equitySEC
Apr 2011$4 MNo. 1$2 to $10 million

EndoShape, Inc.: Raise no. 1, Apr 2011

Investors in this round

2 investors had bought by the notice of Apr 18, 2011: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robin Shandas · Executive Officer, Director
  • William Aldrich · Executive Officer, Director
  • Donald Geer · Director
  • Lee Geist · Director
  • Mark Lupa · Director
  • Shawn Fojtik · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William Aldrich, Ceo. Source: SEC Form D, newest notice filed Apr 18, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • EndoShape, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2017).

    SEC Form D · Mar 2017

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Feb 2017

That is all the official record says: EndoShape, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of EndoShape, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 17 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by EndoShape, Inc.
NameRoleNamed in
Robert KlineExecutive officerMar 2017
Robin ShandasExecutive officerJan 2016
William AldrichExecutive officerJan 2016
Bryan GrulkeDirectorMar 2017
James McGuckinDirectorMar 2017
Lee GeistDirectorMar 2017
Lindsay CarterDirectorMar 2017
Mark LupaDirectorMar 2017
Richard FerrariDirectorMar 2017
Robert KlineDirectorMar 2017
Robin ShandasDirectorJan 2016
Shawn FojtikDirectorJan 2016
William AldrichDirectorJan 2016
Donald GeerDirectorApr 2011